{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:04:26Z","timestamp":1697439866228},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.bcp.2004.10.013","type":"journal-article","created":{"date-parts":[[2004,12,12]],"date-time":"2004-12-12T00:47:11Z","timestamp":1102812431000},"page":"485-491","source":"Crossref","is-referenced-by-count":5,"title":["3,5-Di-t-butylcatechol (DTCAT) as an activator of rat skeletal muscle ryanodine receptor Ca2+ channel (RyRC)"],"prefix":"10.1016","volume":"69","author":[{"given":"Fabio","family":"Fusi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donata","family":"Iozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampietro","family":"Sgaragli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Frosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2004.10.013_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0143416002001823","article-title":"The endoplasmic reticulum: a multifunctional signaling organelle","volume":"32","author":"Berridge","year":"2002","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bcp.2004.10.013_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/316446a0","article-title":"Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels","volume":"316","author":"Smith","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2004.10.013_bib3","series-title":"Ion channel pharmacology","article-title":"Intracellular channels in muscle","author":"Jaimovich","year":"1998"},{"key":"10.1016\/j.bcp.2004.10.013_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/339439a0","article-title":"Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor","volume":"339","author":"Takeshima","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2004.10.013_bib5","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0021-9258(19)39968-5","article-title":"Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum","volume":"265","author":"Zorzato","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.10.013_bib6","first-page":"147","article-title":"Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle","volume":"58","author":"Monnier","year":"2000","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.bcp.2004.10.013_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/geno.1993.1302","article-title":"Multipoint mapping of the central core disease locus","volume":"17","author":"Schwemmle","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2004.10.013_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/bj2900259","article-title":"Subcellular membrane characterization of [3H]ryanodine-binding sites in smooth muscle","volume":"290","author":"Zhang","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2004.10.013_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jnnp.57.7.843","article-title":"Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis","volume":"57","author":"Mygland","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bcp.2004.10.013_bib10","doi-asserted-by":"crossref","first-page":"C195","DOI":"10.1152\/ajpcell.1991.261.2.C195","article-title":"Cellular mechanisms of fatigue in skeletal muscle","volume":"261","author":"Westerblad","year":"1991","journal-title":"Am J Physiol."},{"key":"10.1016\/j.bcp.2004.10.013_bib11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF00375074","article-title":"Prolonged exercise reduces Ca2+ release in rat skeletal muscle sarcoplasmic reticulum","volume":"422","author":"Favero","year":"1993","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.bcp.2004.10.013_bib12","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1074\/jbc.272.8.5256","article-title":"Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle","volume":"272","author":"Richter","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.10.013_bib13","first-page":"1","article-title":"The sarcoplasmic reticulum Ca2+ channel\/ryanodine receptor: modulation by endogenous effectors, drugs and disease states","volume":"49","author":"Zucchi","year":"1997","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2004.10.013_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1589759","article-title":"Malignant hyperthermia","volume":"256","author":"MacLennan","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bcp.2004.10.013_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1476-5381.1993.tb13819.x","article-title":"Calcium antagonist and antiperoxidant properties of some hindered phenols","volume":"110","author":"Sgaragli","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib16","first-page":"524","article-title":"NDGA inhibits voltage-activated Ca2+ currents independently of lipoxygenase inhibition","volume":"38","author":"Korn","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(98)00660-8","article-title":"Myorelaxant activity of 2-t-butyl-4-methoxyphenol (BHA) in guinea pig gastric fundus","volume":"360","author":"Fusi","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(00)00152-7","article-title":"On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings","volume":"394","author":"Fusi","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/sj.bjp.0703935","article-title":"Effects of some sterically hindered phenols on whole-cell Ca2+ current of guinea pig gastric fundus smooth muscle cells","volume":"132","author":"Fusi","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0006-2952(01)00794-8","article-title":"3,5-di-t-butyl-4-hydroxyanisole (DTBHA) activation of rat skeletal muscle sarcoplasmic reticulum Ca(2+)-ATPase","volume":"62","author":"Fusi","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0006-2952(88)90195-5","article-title":"Cyclopiazonic acid inhibition of the Ca2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles","volume":"37","author":"Goeger","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.99.3.875","article-title":"Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle","volume":"99","author":"Saito","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2004.10.013_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0003-2697(76)80064-4","article-title":"Assay of proteins in the presence of interfering materials","volume":"70","author":"Bensadoun","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2004.10.013_bib24","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1016\/S0021-9258(18)45548-2","article-title":"Drug-induced Ca2+ release from isolated sarcoplasmic reticulum. I. Use of pyrophosphate to study caffeine-induced Ca2+ release","volume":"262","author":"Palade","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.10.013_bib25","first-page":"463","article-title":"Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells","volume":"75","author":"Fabiato","year":"1979","journal-title":"J Physiol (Paris)"},{"key":"10.1016\/j.bcp.2004.10.013_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0014-5793(01)03013-7","article-title":"Imperatoxin A (IpTx(a)) from Pandinus imperator stimulates [(3)H]ryanodine binding to RyR3 channels","volume":"508","author":"Simeoni","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2004.10.013_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0003-2697(80)90515-1","article-title":"Ligand: a versatile computerized approach for characterization of ligand-binding systems","volume":"107","author":"Munson","year":"1980","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2004.10.013_bib28","series-title":"Neurotransmitter receptor analysis","first-page":"37","article-title":"Computer analysis of binding data in methods","author":"Unnerstall","year":"1990"},{"key":"10.1016\/j.bcp.2004.10.013_bib29","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibitory constant (Ki) and the concentrations of an inhibitor which causes 50 per cent inhibition (IC50) of an enzyme reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib30","first-page":"1192","article-title":"Chlorocresol: an activator of ryanodine receptor-mediated Ca2+ release","volume":"44","author":"Zorzato","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1085\/jgp.102.6.1031","article-title":"Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle","volume":"102","author":"Ma","year":"1993","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.bcp.2004.10.013_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00240306","article-title":"Ryanodine as a functional probe of the skeletal muscle sarcoplasmic reticulum Ca2+ release channel","volume":"114","author":"Meissner","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bcp.2004.10.013_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-2952(96)00175-X","article-title":"4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle","volume":"52","author":"Herrmann-Frank","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.10.013_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-4165(95)00131-X","article-title":"4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor","volume":"1289","author":"Herrmann-Frank","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2004.10.013_bib35","doi-asserted-by":"crossref","first-page":"28727","DOI":"10.1074\/jbc.M303821200","article-title":"Identification of a key determinant of ryanodine receptor type 1 required for activation by 4-chloro-m-cresol","volume":"278","author":"Fessenden","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.10.013_bib36","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/00000542-199606000-00014","article-title":"Chlorocresol: an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel","volume":"84","author":"Tegazzin","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bcp.2004.10.013_bib37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1399-6576.1997.tb04821.x","article-title":"4-Chloro-m-cresol test\u2014a possible supplementary test for diagnosis of malignant hyperthermia susceptibility","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bcp.2004.10.013_bib38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00000539-200001000-00040","article-title":"A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility","volume":"90","author":"Baur","year":"2000","journal-title":"Anesth Analg"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295204007336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295204007336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T03:38:18Z","timestamp":1625110698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295204007336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0006295204007336"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2004.10.013","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}